Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
World Congress of Cardiology
Critical Choices in Chronic Heart Failure Management
Barcelona, Spain / September 2-6, 2006
Barcelona - Risk assessment of patients with chronic heart failure (CHF) help determine the intensity of disease and choice of treatment strategies. Candesartan in Heart Failure-Assessment of Reduction in Mortality and Morbidity (CHARM) was...
16th World Congress of the World Society of Cardio-Thoracic Surgeons
Strategies to Minimize Blood Loss in the Cardiac Surgery Setting
Ottawa, Ontario / August 17-20, 2006
Ottawa - Blood conservation strategies revolve around correcting risk factors for post-operative bleeding prior to surgery, meticulous surgical technique and restricted use of transfusion products. Correctable risk factors include...
13th World Conference on Tobacco or Health
Combining Behavioural Counselling with Pharmacological Therapy: A Viable Formula for Smoking Cessation
Washington, DC / July 12-15, 2006
Washington, DC - Double-blind controlled trials have demonstrated that the relative specificity of pharmacologic therapies directed at central mediators of tobacco addiction appear to promote longer remission from smoking, according to...
9th Annual Toronto International Heart Failure Summit
From Pathophysiology to Clinical Practice
Toronto, Ontario / June 14-16, 2006
Toronto - The past year has been one of consolidation of knowledge about the diagnosis and management of heart failure. At the 9th Annual Conference of the Toronto International Heart Failure Summit, key opinion leaders met to discuss the...
16th European Meeting on Hypertension
The Role of Angiotensin II Antagonism in Stroke Prevention
Madrid, Spain / June 12-15, 2006
Madrid - Angiotensin II antagonists (AIIAs) have become an important option for treating hypertension. Recent data were represented here during the scientific sessions that further confirm their efficacy in lowering blood pressure (BP),...
66th Scientific Sessions of the American Diabetes Association
Treating Patients with the Metabolic Syndrome and Type 2 Diabetes: A Step Beyond Statins
Washington, DC / June 9-13, 2006
Washington - In Canada, there are now more than 2 million patients with type 2 diabetes of whom about two-thirds will die of cardiovascular disease. Approximately 25% of Canadians have the metabolic syndrome, which by itself has been...
Euroanaesthesia 2006 Annual Meeting of the European Society of Anaesthesiology
Cardioprotection with Volatile Anesthetics
Madrid, Spain / June 3-6, 2006
Madrid - Experimental studies have regularly indicated that volatile anesthetics significantly protect the myocardium from ensuing ischemia-reperfusion injury in varied surgical settings independently of their known effects on myocardial...
15th Annual Meeting of the American Association of Clinical Endocrinologists
Estimating the Overall Event Reduction in Type 2 Diabetes Patients with Fibrate Therapy
Chicago, Illinois / April 26-30, 2006
Chicago - According to the Centers for Disease Control and Prevention, nearly 21 million Americans (or 7% of the population) have diabetes and carry a two- to fourfold greater risk of heart disease or stroke compared with the general...
First International Conference on Hypertension, Lipids, Diabetes and Stroke Prevention
Blood Pressure Control and Beyond: Optimal Reduction of Stroke Risk
Paris, France / March 30-April 1, 2006
Paris - According to international investigators gathered here this week, the single largest contributor to stroke is elevated blood pressure (BP). Experts agree that all antihypertensive classes reduce stroke risk by between 30% and 40%...